Christopher Sie

Christopher Sie

Auto-generated profile, based on publicly available information

Christopher Sie

Institute for Experimental Neuroimmunology, Technical University of Munich School of Medicine and Health , 81675 Munich

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2018 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
BKBenjamin Knier
Benjamin Knier
MHMichael Hiltensperger
Michael Hiltensperger
CSChristopher Sie
Christopher Sie
LALilian Aly
Lilian Aly
GLGildas Lepennetier
Gildas Lepennetier
TKThomas Korn
Thomas Korn

21 February 2024 in Nature
Verified
Journal Article
Open access
PDF file
AAAli Maisam Afzali
Ali Maisam Afzali
LNLucy Nirschl
Lucy Nirschl
CSChristopher Sie
Christopher Sie
MPMonika Pfaller
Monika Pfaller
OUOleksii Ulianov
Oleksii Ulianov
TKThomas Korn
Thomas Korn
Neuromyelitis optica is a paradigmatic autoimmune disease of the central nervous system, in which the water-channel protein AQP4 is the target antigen1. The immunopathology in neuromyelitis optica is largely driven by autoantibodies to AQP42. However, the T cell response that is required for the generation of these anti-AQP4 antibodies is not well understood. Here we show that B cells endogenously express AQP4 in response to activation with anti-CD40 and IL-21 and are able to present their endogenous AQP4 to T cells with an AQP4-specific T cell receptor (TCR). A population of thymic B cells emulates a CD40-stimulated B cell transcriptome, including AQP4 (in mice and humans), and efficiently purges the thymic TCR repertoire of AQP4-reactive clones. Genetic ablation of Aqp4 in B cells rescues AQP4-specific TCRs despite sufficient expression of AQP4 in medullary thymic epithelial cells, and B-cell-conditional AQP4-deficient mice are fully competent to raise AQP4-specific antibodies in productive germinal-centre responses. Thus, the negative selection of AQP4-specific thymocytes is dependent on the expression and presentation of AQP4 by thymic B cells. As AQP4 is expressed in B cells in a CD40-dependent (but not AIRE-dependent) manner, we propose that thymic B cells might tolerize against a group of germinal-centre-associated antigens, including disease-relevant autoantigens such as AQP4.

7 June 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
MHMichael Hiltensperger
Michael Hiltensperger
EBEduardo Beltrán
Eduardo Beltrán
RKRavi Kant
Ravi Kant
STSofia Tyystjärvi
Sofia Tyystjärvi
GLGildas Lepennetier
Gildas Lepennetier
TKThomas Korn
Thomas Korn

9 March 2021 in Brain
Verified
Journal Article
Closed access
PDF file
MMMeike Mitsdoerffer
Meike Mitsdoerffer
GLGiovanni Di Liberto
Giovanni Di Liberto
SDSarah Dötsch
Sarah Dötsch
CSChristopher Sie
Christopher Sie
IWIngrid Wagner
Ingrid Wagner
TKThomas Korn
Thomas Korn
Meningeal B lymphocyte aggregates have been described in autopsy material of patients with chronic multiple sclerosis. The presence of meningeal B cell aggregates has been correlated with worse disease. However, the functional role of these meningeal B cell aggregates is not understood. Here, we use a mouse model of multiple sclerosis, the spontaneous opticospinal encephalomyelitis model, which is built on the double transgenic expression of myelin oligodendrocyte glycoprotein-specific T-cell and B-cell receptors, to show that the formation of meningeal B cell aggregates is dependent on the expression of α4 integrins by antigen-specific T cells. T cell-conditional genetic ablation of α4 integrins in opticospinal encephalomyelitis mice impaired the formation of meningeal B cell aggregates, and surprisingly, led to a higher disease incidence as compared to opticospinal encephalomyelitis mice with α4 integrin-sufficient T cells. B cell-conditional ablation of α4 integrins in opticospinal encephalomyelitis mice resulted in the entire abrogation of the formation of meningeal B cell aggregates, and opticospinal encephalomyelitis mice with α4 integrin-deficient B cells suffered from a higher disease burden than regular opticospinal encephalomyelitis mice. While anti-CD20 antibody-mediated systemic depletion of B cells in opticospinal encephalomyelitis mice after onset of disease failed to efficiently decrease meningeal B cell aggregates without significantly modulating disease progression, treatment with anti-CD19 chimeric antigen receptor-T cells eliminated meningeal B cell aggregates and exacerbated clinical disease in opticospinal encephalomyelitis mice. Since about 20% of B cells in organized meningeal B cell aggregates produced either IL-10 or IL-35, we propose that meningeal B cell aggregates might also have an immunoregulatory function as to the immunopathology in adjacent spinal cord white matter. The immunoregulatory function of meningeal B cell aggregates needs to be considered when designing highly efficient therapies directed against meningeal B cell aggregates for clinical application in multiple sclerosis.

16 June 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
KLKonstantin Lutz
Konstantin Lutz
AMAndrea Musumeci
Andrea Musumeci
CSChristopher Sie
Christopher Sie
EDEzgi Dursun
Ezgi Dursun
EWElena Winheim
Elena Winheim
AKAnne B. Krug
Anne B. Krug
Plasmacytoid and conventional dendritic cells (pDC and cDC) are generated from progenitor cells in the bone marrow and commitment to pDCs or cDC subtypes may occur in earlier and later progenitor stages. Cells within the CD11c+MHCII−/loSiglec-H+CCR9lo DC precursor fraction of the mouse bone marrow generate both pDCs and cDCs. Here we investigate the heterogeneity and commitment of subsets in this compartment by single-cell transcriptomics and high-dimensional flow cytometry combined with cell fate analysis: Within the CD11c+MHCII−/loSiglec-H+CCR9lo DC precursor pool cells expressing high levels of Ly6D and lacking expression of transcription factor Zbtb46 contain CCR9loB220hi immediate pDC precursors and CCR9loB220lo (lo-lo) cells which still generate pDCs and cDCs in vitro and in vivo under steady state conditions. cDC-primed cells within the Ly6DhiZbtb46– lo-lo precursors rapidly upregulate Zbtb46 and pass through a Zbtb46+Ly6D+ intermediate stage before acquiring cDC phenotype after cell division. Type I IFN stimulation limits cDC and promotes pDC output from this precursor fraction by arresting cDC-primed cells in the Zbtb46+Ly6D+ stage preventing their expansion and differentiation into cDCs. Modulation of pDC versus cDC output from precursors by external factors may allow for adaptation of DC subset composition at later differentiation stages.

12 July 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
CSChristopher Sie
Christopher Sie
RKRavi Kant
Ravi Kant
CPChristian Peter
Christian Peter
AMAndreas Muschaweckh
Andreas Muschaweckh
MPMonika Pfaller
Monika Pfaller
TKThomas Korn
Thomas Korn
In certain instances, Th17 responses are associated with severe immunopathology. T cell–intrinsic mechanisms that restrict pathogenic effector functions have been described for type 1 and 2 responses but are less well studied for Th17 cells. Here, we report a cell-intrinsic feedback mechanism that controls the pathogenicity of Th17 cells. Th17 cells produce IL-24, which prompts them to secrete IL-10. The IL-10–inducing function of IL-24 is independent of the cell surface receptor of IL-24 on Th17 cells. Rather, IL-24 is recruited to the inner mitochondrial membrane, where it interacts with the NADH dehydrogenase (ubiquinone) 1 α subcomplex subunit 13 (also known as Grim19), a constituent of complex I of the respiratory chain. Together, Grim19 and IL-24 promote the accumulation of STAT3 in the mitochondrial compartment. We propose that IL-24–guided mitochondrial STAT3 constitutes a rheostat to blunt extensive STAT3 deflections in the nucleus, which might then contribute to a robust IL-10 response in Th17 cells and a restriction of immunopathology in experimental autoimmune encephalomyelitis.